Secondary Prevention in Coronary Artery Disease and Myocardial Infarction

Secondary Prevention in Coronary Artery Disease and Myocardial Infarction edited by P. Mathes.

Despite considerable effort in primary prevention, coronary heart disease continues to be the leading cause of death in the industrialized nations. The patient who survives his first myocardial infarction carries approximately a tenfold risk of recurrence and sudden death when compared to the normal...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Mathes, P. (Editor)
Format: eBook
Language:English
Published: Dordrecht : Springer Netherlands : Imprint: Springer, 1985.
Edition:1st ed. 1985.
Series:Developments in Cardiovascular Medicine, 48
Springer eBook Collection.
Subjects:
Cardiology.
Electronic resources (E-books)
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
Table of Contents:
  • One: The Role of Risk Factors in Secondary Prevention
  • 1. Cessation of Smoking
  • 2. The Importance of the Cessation of Cigarette Smoking in the Tertiary Prevention of Coronary Heart Disease
  • 3. Control of Hypertension
  • 4. Lipid Lowering Regimens in Secondary Prevention of Coronary Heart Disease
  • Two: The Role of Social Class in Secondary Prevention
  • 5. Mortality after Myocardial Infarction. Role of Social and Behavioral Factors
  • 6. The Impact of Social Level on Prognosis after Myocardial Infarction
  • 7. Social Class and Prognosis in Coronary Heart Disease
  • 8. Short and Long-term Prognosis After First Myocardial Infarction. Influences of Social Class
  • Three: The Role of Medication in Secondary Prevention
  • 9. Beta-blocking Agents in Secondary Prevention
  • 10. Beta-Blocking Agents in Secondary Prevention After Acute Myocardial Infarction with Special Reference to the European Infarct Study (EIS)
  • 11. Platelet Aggregation Inhibitors
  • 12. Platelet Inhibitors or Anticoagulants for Prevention of Aorto-coronary Bypass Graft Occlusion
  • 13. Cardiovascular Protection by Calcium Antagonists
  • 14. The Influence of Nitrates on Prognosis in Patients with Coronary Heart Disease
  • 15. Metabolic Aspects of Preventive Drug Administration
  • Four: The Role of Physical Exercise in Secondary Prevention
  • 16. The Role of Physical Exercise in Secondary Prevention. Evidence to Date
  • 17. The Behavior of the Ejection Fraction at Rest and Exercise in Myocardial Infarction Before and After a 4-week Training Period. Comparison to a Control Group
  • 18. Adaptations to Prolonged Intense Exercise Training in Ischemic Heart Disease
  • 19. Physical Activity and Sudden Death
  • 20. Physical Exercise and Sympathetic Drive
  • 21. Physical Exercise in Comprehensive Care
  • 22. Exercise Capacity and Regional Myocardial Perfusion Distribution in Ischemic Heart Disease with and without Collateral Vessels
  • Five: The Role of Psychosocial Factors in Secondary Prevention
  • 23. Alteration of Type A Behavior and its Effect Upon the Cardiac Recurrence Rate in Post-myocardial Infarction Patients
  • 24. A 5-year Controlled Clinical Trial on Psychological Well-being
  • 25. Psychosomatic Aspects in Secondary Prevention
  • 26. Social Isolation and Attitudes Towards Stress. A Behavioral Trap for Patients After Myocardial Infarction
  • Six: The Role of Reperfusion in Secondary Prevention
  • 27. Effect of Percutaneous Transluminal Coronary Angioplasty
  • 28. Single Vessel Stenosis After Acute Myocardial Infarction: Which Patients Should Undergo Percutaneous Transluminal Coronary Angioplasty?
  • 29. The Role of Coronary Bypass Surgery in Rehabilitation
  • 30. Social Fate after Aorto-coronary Bypass Surgery
  • 31. Clinical and Occupational Status of Patients with Coronary Artery Disease After Surgical Reperfusion
  • 32. Which Factors do Influence the Rate of Employment After Surgical and Medical Treatment in Patients with Coronary Heart Disease?
  • 33. Late Results of Reperfusion with Intracoronary Streptokinase
  • 34. Percutaneous Transluminal Coronary Angioplasty After Thrombolysis to Prevent Reinfarction.

Similar Items